Skip to main content
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.997
+0.030 (3.09%)
At close: Mar 9, 2026, 4:00 PM EDT
1.000
+0.004 (0.35%)
After-hours: Mar 9, 2026, 7:14 PM EDT

Heron Therapeutics Revenue

In the year 2025, Heron Therapeutics had annual revenue of $154.90M with 7.36% growth. Heron Therapeutics had revenue of $40.59M in the quarter ending December 31, 2025, a decrease of -0.47%.

Revenue (ttm)
$154.90M
Revenue Growth
+7.36%
P/S Ratio
1.17
Revenue / Employee
$1,210,188
Employees
128
Market Cap
187.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025154.90M10.62M7.36%
Dec 31, 2024144.29M17.24M13.57%
Dec 31, 2023127.04M19.37M17.99%
Dec 31, 2022107.67M21.33M24.70%
Dec 31, 202186.35M-2.29M-2.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vaxart 148.20M
ProQR Therapeutics 18.86M
Whitehawk Therapeutics 14.38M
Cartesian Therapeutics 1.09M
Molecular Partners AG 856.30K
SAB Biotherapeutics 114.70K
NeOnc Technologies Holdings 59.99K
Revenue Rankings

HRTX News

More News